[5tefan]

Means they recover non through this drug and recover all RD through other drugs.

And let's not forget that this business often operates with sickeningly huge profit margins.

[s1artibartfast]

>And let's not forget that this business often operates with sickeningly huge profit margins.

This is grossly misinformed

Looking at the UniQure Tax filings for 2020, They had 37M in revenue, -122M in R&D expenses, and -42M in general expenses, so they were -125M in the hole that year.

https://uniqure.gcs-web.com/static-files/8f960e6d-c40c-474e-...

[5tefan]

I work in finance and of course it is not true for every company and I didn't refer to them.

From a collegue I know that they purged drugs from their portfolio because it made less than <80% net profit.

But you are right. It is very different.

[s1artibartfast]

Who are you referring to in your 80% example? Also, what do you mean by purged? Do you mean stopping manufacturing of an approved product?

No company is gonna cut a an approved drug with hundreds of million in net profit because the % profit is <80. I could see them cutting drugs if the total profit is low tho. This helps them focus on other more profitable drugs with. That is to say, most companies don't want to be making 100 products that net low millions each. They want a few products that make 100 million+ each.

[5tefan]

I will not disclose the company name.

With purged I mean exactly this. Purged. 80% was low from their point of view. Don't know how many products they had. Couldn't believe it at all.

[s1artibartfast]

Sounds like I see it as more believable than you, but with the caveats that I added in my parent company. I doubt <80% was the only reason and any of the products were massive revenue makers.